Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway
Journal of Pharmaceutical Analysis · 2024-08 · 14 (8) · 100946
DOI: 10.1016/j.jpha.2024.01.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2024-08. Verfasst von Jiabin Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Lab of Human Performance, Shanghai University of Sport, Shanghai, 200438, China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 234 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic nephropathy (DN), a severe complication of diabetes, is widely recognized as a primary contributor to end-stage renal disease. Recent studies indicate that the inflammation triggered by Toll-like receptor 4 (TLR4) is of paramount importance in the onset and progression of DN. TLR4 can bind to various ligands, including exogenous ligands such as proteins and polysaccharides from bacteria or viruses, as well as endogenous ligands such as biglycan, fibrinogen, and hyaluronan. In DN, the expression or release of TLR4-related ligands is significantly elevated, resulting in excessive TLR4 activation and increased production of proinflammatory cytokines through downstream signaling pathways. This process is closely associated with the progression of DN. Natural compounds are biologically active products derived from natural sources that have advantages in the treatment of certain diseases. Various types of natural compounds, including alkaloids, flavonoids, polyphenols, terpenoids, glycosides, and polysaccharides, have demonstrated their ability to improve DN by affecting the TLR4 signaling pathway. In this review, we summarize the mechanism of action of TLR4 in DN and the natural compounds that can ameliorate DN by modulating the TLR4 signaling pathway. We specifically highlight the potential of compounds such as curcumin, paclitaxel, berberine, and ursolic acid to inhibit the TLR4 signaling pathway, which provides an important direction of research for the treatment of DN.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Key Lab of Human Performance, Shanghai University of Sport, Shanghai, 200438, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Li, K., Zhou, M., Gao, H., Wang, W., & Xiao, W. (2024). Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. Journal of Pharmaceutical Analysis, 14(8), 100946. https://doi.org/10.1016/j.jpha.2024.01.014
Vancouver
Wu J, Li K, Zhou M, Gao H, Wang W, Xiao W. Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. Journal of Pharmaceutical Analysis. 2024;14(8):100946. doi:10.1016/j.jpha.2024.01.014
BibTeX
@article{Wu2024,
author = {Wu, Jiabin and Li, Ke and Zhou, Muge and Gao, Haoyang and Wang, Wenhong and Xiao, Weihua},
title = {Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway},
journal = {Journal of Pharmaceutical Analysis},
year = {2024},
volume = {14},
number = {8},
pages = {100946},
doi = {10.1016/j.jpha.2024.01.014}
}
EUVIMED